Stocks and Investing Stocks and Investing
Tue, August 15, 2023

Ed Arce Maintained (ACXP) at Strong Buy with Decreased Target to $13 on, Aug 15th, 2023


Published on 2024-10-28 05:54:51 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Acurx Pharmaceuticals, Inc." (ACXP) at Strong Buy with Decreased Target from $14 to $13 on, Aug 15th, 2023.

Ed, nor any peers, have made any analyst calls on ACXP in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources